Biologic Drugs

Oct 02, 2010
Pharmaceutical Technology
Drugmakers hatch new manufacturing paradigms in the wake of the 2009 H1N1 influenza pandemic.
Oct 01, 2010
Pharmaceutical Technology
By Pharmaceutical Technology Editors
The authors describe the operational requirements and design of a process-ready PAT-based IBD system.
Sep 16, 2010
ePT--the Electronic Newsletter of Pharmaceutical Technology
The generic-drug company Actavis (Hafnarfjordur, Iceland) is considering acquiring a 51% stake in the biopharmaceutical company BioPartners Holdings (Barr, Switzerland) from Bioton, a Polish biotechnology company.
Sep 15, 2010
Equipment and Processing Report
By Pharmaceutical Technology Editors
The author describes the types and sources of rouge and explains ways to prevent and mitigate this problem.
Sep 01, 2010
Pharmaceutical Technology Europe
In light of the impressive size and predicted growth of the market, there has been a rising interest in the development of biosimilars.
Sep 01, 2010
Pharmaceutical Technology Europe
By Pharmaceutical Technology Editors
Both biosimilar and generic drugs have an abbreviated approval process; however, the clinical trial requirements differ enormously.
Aug 01, 2010
Pharmaceutical Technology Europe
By Pharmaceutical Technology Editors
Why the primary defence against biosimilars is to develop better molecules that can be launched quickly.
Aug 01, 2010
Pharmaceutical Technology Europe
By Pharmaceutical Technology Editors
As biopharmaceuticals will soon make up 50% of new drug approvals there has been a significant rise in interest in the field of biosimilars.
Aug 01, 2010
Pharmaceutical Technology Europe
By Pharmaceutical Technology Editors
We speak to The European generic Medicines Association about the environment for biosimilars.
Aug 01, 2010
Pharmaceutical Technology Europe
By Pharmaceutical Technology Editors
The different pathways to regulatory approval of a biosimilar vary worldwide, ranging from no pathways at all in some developing countries, to the complex and precise mechanism that exists in Europe.
native1_300x100
lorem ipsum